# Early Feasibility Study of "HyperQureTM RDN System", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension

> **NCT06526858** · NA · RECRUITING · sponsor: **DeepQure Inc.** · enrollment: 15 (estimated)

## Conditions studied

- Resistant Hypertension

## Interventions

- **DEVICE:** HyperQureTM Renal Denervation (RDN) System:

## Key facts

- **NCT ID:** NCT06526858
- **Lead sponsor:** DeepQure Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-21
- **Primary completion:** 2026-06-18
- **Final completion:** 2029-03-20
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06526858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06526858, "Early Feasibility Study of "HyperQureTM RDN System", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06526858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*